Norton Healthcare has expanded its research efforts with the creation of Norton Research Institute, the central entity overseeing all research throughout the organization, including clinical trials, across a multitude of specialties. Nearly 1,000 active studies currently are underway. This is an enormous increase from eight active oncology and cardiology studies in 2005, which was just…
Today Norton Healthcare announced an expansion of research efforts with the creation of Norton Research Institute, the central entity overseeing all research throughout the organization, including clinical trials, across a multitude of specialties. Nearly 1,000 active studies currently are underway. This is an enormous increase from eight active oncology and cardiology studies in 2005, which…
Norton Infectious Diseases Institute has been selected by Pfizer as the only site in United States to study how to effectively detect respiratory syncytial virus (RSV) in adults. “For the most part, RSV attention has been focused on children,” said Julio A. Ramirez, M.D., FACP, chief scientific officer, Norton Infectious Diseases Institute. “But some studies…
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S. The Phase 3…
Norton Healthcare is one of the first in the nation to study convalescent plasma as a therapy to prevent high-risk patients with COVID-19, the disease caused by the coronavirus, from getting seriously ill. Convalescent plasma is taken from blood donated by fully recovered COVID-19 patients. The goal is to determine if the plasma can help…
As patients continue to be diagnosed with COVID-19, the disease caused by the coronavirus, Norton Healthcare is looking for ways to help them overcome the infection. Norton Healthcare is the first in the world to enroll COVID-19 patients in two new clinical trials after becoming the first to participate in a randomized Phase 2 clinical…
Renato V. LaRocca, M.D., values the opportunity to be at the forefront of brain cancer research. As a neuro-oncologist and cancer medicine specialist with Norton Cancer Institute, Dr. LaRocca has treated many cases of glioblastoma. He is grateful to have been part of a clinical trial to assess the effectiveness of a novel immunotherapy vaccine…
With COVID-19 weakening her body, Hannah Jones, 24, was at risk of a heart attack. She was placed on a ventilator so she could breathe. It was very possible she would die. Two days after getting an infusion of plasma donated by a COVID-19 survivor, she was out of intensive care and on the road…
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been able to go home. Norton Healthcare physicians have been testing the treatment for COVID-19 that has shown promise in smaller studies around the world. The…
Norton Healthcare Foundation announced that it received a $125,000 grant from the PNC Foundation to assist it in supporting COVID-19 relief efforts in the community. The funds will be used to provide antibody testing as part of the Norton Healthcare Convalescent Plasma Program, make additional testing available for patients and provide meals for employees. “We’re…
Norton Healthcare specialists are researching a variety of experimental therapies as possible treatments for patients with COVID-19. These therapies fall into four categories: Agents that work to prevent the virus from growing: Medications are being used to either kill the virus or prevent it from growing. Drugs that block or lessen the profound inflammation that…
Physicians around the country are testing a possible treatment for COVID-19 using plasma taken from blood donated by fully recovered COVID-19 patients, called convalescent plasma. Locally, Norton Healthcare began offering this experimental treatment in early April and has transfused 21 patients who were critically ill with COVID-19. Of those, six have been well enough to…
Select an appointment date and time from available spots listed below.